The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study by Ismail, I.S., Webster, J., Piscitelli, G., Polli, A., D'Alberton, A., Falsetti, L., Ferrari, C., Fioretti, P., Giordano, G., L'Hermite, M., Ciccarelli, E., Crosignani, P.G., DeCecco, L., Fadini, R., Faglia, G., Flamigni, C., Tamburrano, G., Scanlon, M.F.

Get full text

Guidelines for diagnosis and therapy of MEN type 1 and type 2. by Brandi, M, Gagel, R, Angeli, A, Bilezikian, J, Beck-Peccoz, P, Bordi, C, Conte-Devolx, B, Falchetti, A, Gheri, R, Libroia, A, Lips, C, Lombardi, G, Mannelli, M, Pacini, F, Ponder, B, Raue, F, Skogseid, B, Tamburrano, G, Thakker, R, Thompson, N, Tomassetti, P, Tonelli, F, Wells, SA, Marx, S

Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2 by Brandi, M, Gagel, R, Angeli, A, Bilezikian, J, Beck-Peccoz, P, Bordi, C, Conte-Devolx, B, Falchetti, A, Gheri, R, Libroia, A, Lips, C, Lombardi, G, Mannelli, M, Pacini, F, Ponder, B, Raue, F, Skogseid, B, Tamburrano, G, Thakker, R, Thompson, N, Tomassetti, P, Tonelli, F, Wells S A, J, Marx, S